About Plasbumin 20
Grifols Human Albumin I.P. 20% Injection is a sterile, non-pyrogenic solution of human albumin prepared from human plasma using advanced fractionation and purification techniques. It is widely used for plasma volume expansion and maintenance of colloid osmotic pressure in patients with hypovolemia and hypoalbuminemia.
This high-purity albumin solution is manufactured following stringent quality and safety standards to ensure maximum efficacy and patient safety.
Uses / Indications
-
Treatment of hypovolemia
-
Management of hypoalbuminemia
-
Plasma volume replacement
-
Supportive therapy in liver failure
-
Burns and trauma cases
-
Major surgical procedures
-
Nephrotic syndrome (as prescribed)
Key Benefits
-
High-purity, plasma-derived human albumin
-
Helps restore and maintain blood volume
-
Maintains oncotic pressure
-
Low risk of adverse reactions
-
Manufactured under strict GMP standards
Dosage & AdministrationDosage and infusion rate should be determined by the physician based on the patients clinical condition, body weight, and response to treatment.
Storage InstructionsBenefits and Applications of Plasbumin 20Plasbumin 20 is renowned for its effectiveness in managing hypovolemia, addressing hypoalbuminemia, supporting patients with burn injuries, and aiding in procedures like cardiopulmonary bypass. Its rapid restoration of plasma volume helps stabilize patients quickly, while its high purity and viral safety offer peace of mind for medical professionals and patients alike.
Safe Storage and Shelf LifeStore Plasbumin 20 between 2C to 8C, away from light and never frozen, to maintain product integrity. Each vial is single-use, ensuring sterility and reducing contamination risks. Once opened, use the solution within 24 hours to ensure maximum efficacy and safety for patients.
Viral Safety and PurityEvery batch of Plasbumin 20 undergoes thorough viral inactivation, including pasteurization, to eliminate potential pathogens. This guarantees a product free from preservatives and pyrogens, making it suitable for critical clinical applications requiring high safety standards. Its manufacturing process aligns with international quality norms.
FAQ's of Plasbumin 20:
Q: How should Plasbumin 20 be administered to patients?
A: Plasbumin 20 should be administered by intravenous infusion only, using a single-use glass vial. The infusion rate and dose depend on the patient's clinical status and condition being treated, and must be determined by a healthcare professional.
Q: What safety measures are in place regarding viruses in Plasbumin 20?
A: Plasbumin 20 is manufactured with multiple steps for viral inactivation and removal, including pasteurization. This makes the product highly safe and significantly reduces the risk of transmitting infections.
Q: When is the use of Plasbumin 20 contraindicated?
A: Plasbumin 20 should not be used in individuals with severe anemia, heart failure, or known hypersensitivity to albumin preparations. Patients should be screened for these conditions before administration.
Q: Where should Plasbumin 20 be stored for optimal safety and effectiveness?
A: Store Plasbumin 20 at a temperature between 2C and 8C, away from direct light. Do not freeze the vials. Once opened, use the content within 24 hours to ensure sterility.
Q: What are the key benefits of using Plasbumin 20 in clinical practice?
A: Plasbumin 20 offers rapid and reliable restoration of blood volume, making it highly valuable in treating conditions like hypovolemia, severe burns, and during surgeries like cardiopulmonary bypass. Its sterilized, pyrogen-free nature ensures patient safety.
Q: How is the quality and appearance of Plasbumin 20 verified?
A: Plasbumin 20 is provided as a clear, slightly viscous, pale yellow solution. Its pH ranges from 6.4 to 7.4, and it is free from preservatives and pyrogens, meeting stringent quality standards for medical use.